Since her diagnosis with, and successful treatment for, stage 3 inflammatory breast cancer, Katrece Nolen has been a passionate advocate for other patients.
Read Katrece's StoryThanks to spectacular advances in cancer research, more than 18 million people in the United States and millions more around the world are living with, through, and beyond their diagnoses.
Get InvolvedLourdes Monje was diagnosed with metastatic breast cancer at just 25 years of age. Now, they confront the many unique challenges of a young adult diagnosed with a terminal illness.
Read Lourdes’ StoryMore than 41,000 adults in the United States are expected to be diagnosed with liver cancer. Read about the prevention, screening, and treatment options for liver cancer.
Learn MoreIn this episode of Believe in Progress, the AACR talks with Dr. Christiana Bardon and Mark Haefele to discuss how they are uniting science, finance, and philanthropy to accelerate progress in cancer science and medicine.
Listen and SubscribeRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2025. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More